EF Hutton Reiterates Buy on Upexi, Maintains $7 Price Target
EF Hutton analyst Michael Albanese reiterates Upexi (NASDAQ:UPXI) with a Buy and maintains $7 price target.
Earnings Scheduled For February 14, 2023
Companies Reporting Before The Bell
• WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Gainers
Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Acquisition Of This CBD Gummy Manufacturer Could ‘Position Bloomios To Uplist To Nasdaq’
Bloomios, Inc. (OTCQB: BLMS), has acquired Infusionz, a wholly-owned subsidiary of Upexi Inc. (NASDAQ: UPXI).